Dallongeville J - Search Results

1

Effectiveness and Safety of Rivaroxaban 15 or 20 mg Versus Vitamin K Antagonists in Nonvalvular Atrial Fibrillation.

Blin P, Fauchier L, Dureau-Pournin C, Sacher F, Dallongeville J, Bernard MA, Lassalle R, Droz-Perroteau C, Moore N. Blin P, et al. Among authors: dallongeville j. Stroke. 2019 Sep;50(9):2469-2476. doi: 10.1161/STROKEAHA.119.025824. Epub 2019 Aug 8. Stroke. 2019. PMID: 31390972 Free PMC article.

2

Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study.

Fauchier L, Blin P, Sacher F, Dureau-Pournin C, Bernard MA, Lassalle R, Droz-Perroteau C, Dallongeville J, Moore N. Fauchier L, et al. Among authors: dallongeville j. Europace. 2020 Feb 1;22(2):205-215. doi: 10.1093/europace/euz285. Europace. 2020. PMID: 31638652

3

Xafran, a drug utilization study of rivaroxaban in stroke prevention in atrial fibrillation in France using a claim database.

Dallongeville J, Sacher F, Bouée S, Emery C, Bureau I, Gourmelen J, Fauchier L. Dallongeville J, et al. Therapie. 2018 Dec;73(6):449-460. doi: 10.1016/j.therap.2018.06.003. Epub 2018 Jul 10. Therapie. 2018. PMID: 30075870

4

Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database.

Blin P, Dureau-Pournin C, Benichou J, Bonello L, Dallongeville J, Danchin N, Falissard B, Thomas-Delecourt F, Jové J, Lassalle R, Droz C, Moore N. Blin P, et al. Among authors: dallongeville j. Atherosclerosis. 2019 Feb;281:98-106. doi: 10.1016/j.atherosclerosis.2018.11.037. Epub 2018 Dec 7. Atherosclerosis. 2019. PMID: 30658197

5

Measures of abdominal adiposity and the risk of stroke: the MOnica Risk, Genetics, Archiving and Monograph (MORGAM) study.

Bodenant M, Kuulasmaa K, Wagner A, Kee F, Palmieri L, Ferrario MM, Montaye M, Amouyel P, Dallongeville J; MORGAM Project. Bodenant M, et al. Among authors: dallongeville j. Stroke. 2011 Oct;42(10):2872-7. doi: 10.1161/STROKEAHA.111.614099. Epub 2011 Aug 11. Stroke. 2011. PMID: 21836099

6

Real-life cost of vitamin K antagonist treatment in patients with non-valvular atrial fibrillation in France in 2013.

Dallongeville J, Ansolabehere X, Karusisi N, Maurel F, Van Ganse E, Le Heuzey JY. Dallongeville J, et al. J Med Econ. 2017 Sep;20(9):974-981. doi: 10.1080/13696998.2017.1352508. Epub 2017 Jul 18. J Med Econ. 2017. PMID: 28682153 Free article.

7

Sex Differences in Stroke Attack, Incidence, and Mortality Rates in Northern France.

Meirhaeghe A, Cottel D, Cousin B, Dumont MP, Marécaux N, Amouyel P, Dallongeville J. Meirhaeghe A, et al. Among authors: dallongeville j. J Stroke Cerebrovasc Dis. 2018 May;27(5):1368-1374. doi: 10.1016/j.jstrokecerebrovasdis.2017.12.023. Epub 2018 Feb 21. J Stroke Cerebrovasc Dis. 2018. PMID: 29429886

8

Characteristics and outcomes of patients with multiple cervical artery dissection.

Béjot Y, Aboa-Eboulé C, Debette S, Pezzini A, Tatlisumak T, Engelter S, Grond-Ginsbach C, Touzé E, Sessa M, Metso T, Metso A, Kloss M, Caso V, Dallongeville J, Lyrer P, Leys D, Giroud M, Pandolfo M, Abboud S; CADISP Group. Béjot Y, et al. Among authors: dallongeville j. Stroke. 2014 Jan;45(1):37-41. doi: 10.1161/STROKEAHA.113.001654. Epub 2013 Dec 10. Stroke. 2014. PMID: 24326451 Free article.

9

Characteristics and management of outpatients with history of or current atrial fibrillation: the observational French EPHA study.

Cohen A, Dallongeville J, Durand-Zaleski I, Bouée S, Le Heuzey JY; EPHA Investigators. Cohen A, et al. Among authors: dallongeville j. Arch Cardiovasc Dis. 2010 Jun-Jul;103(6-7):376-87. doi: 10.1016/j.acvd.2010.06.001. Epub 2010 Jul 22. Arch Cardiovasc Dis. 2010. PMID: 20800801 Free article.

10

Relative risks for stroke by age, sex, and population based on follow-up of 18 European populations in the MORGAM Project.

Asplund K, Karvanen J, Giampaoli S, Jousilahti P, Niemelä M, Broda G, Cesana G, Dallongeville J, Ducimetriere P, Evans A, Ferrières J, Haas B, Jorgensen T, Tamosiunas A, Vanuzzo D, Wiklund PG, Yarnell J, Kuulasmaa K, Kulathinal S; MORGAM Project. Asplund K, et al. Among authors: dallongeville j. Stroke. 2009 Jul;40(7):2319-26. doi: 10.1161/STROKEAHA.109.547869. Epub 2009 Jun 11. Stroke. 2009. PMID: 19520994

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

439 results

Search Page